Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. XYZResearchreleased the Global Std Self Diagnostics Market Segment Research Report 2022, which aims to sort out the development status and trends of the Std Self Diagnostics industry at home and abroad, estimate the overall market scale of the Std Self Diagnostics industry and the market share of major countries, analyze the development potential of each segment of the Std Self Diagnostics industry, and study and judge the downstream market demand of Std Self Diagnostics through systematic research, Analyze the competition pattern of Std Self Diagnostics, so as to help solve the pain points of various stakeholders in Std Self Diagnostics industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Std Self Diagnostics Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Std Self Diagnostics Market
Danaher Corporation
Affymetrix
BioMerieux
Cepheid Inc.
Bio-Rad Laboratories
Alere Inc.
DiaSorin
Orasure
F. Hoffmann-La Roche
Abbott Laboratories
Becton Dickinson and Company
Hologic Inc.
Major Type of Std Self Diagnostics Covered in XYZResearch report:
Testing Kit
Testing Device
Testing Strip/chip
Application Segments Covered in XYZResearch Market
Hospitals
Homecare
Diagnostic Centres
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Std Self Diagnostics Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Std Self Diagnostics Market by Value
2.2.1 Global Std Self Diagnostics Revenue by Type
2.2.2 Global Std Self Diagnostics Market by Value (%)
2.3 Global Std Self Diagnostics Market by Production
2.3.1 Global Std Self Diagnostics Production by Type
2.3.2 Global Std Self Diagnostics Market by Production (%)
3. The Major Driver of Std Self Diagnostics Industry
3.1 Historical & Forecast Global Std Self Diagnostics Demand
3.2 Largest Application for Std Self Diagnostics (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Std Self Diagnostics Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Std Self Diagnostics Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Std Self Diagnostics Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Std Self Diagnostics Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Std Self Diagnostics Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Std Self Diagnostics Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Std Self Diagnostics Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Std Self Diagnostics Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Std Self Diagnostics Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Std Self Diagnostics Average Price Trend
12.1 Market Price for Each Type of Std Self Diagnostics in US (2018-2022)
12.2 Market Price for Each Type of Std Self Diagnostics in Europe (2018-2022)
12.3 Market Price for Each Type of Std Self Diagnostics in China (2018-2022)
12.4 Market Price for Each Type of Std Self Diagnostics in Japan (2018-2022)
12.5 Market Price for Each Type of Std Self Diagnostics in India (2018-2022)
12.6 Market Price for Each Type of Std Self Diagnostics in Korea (2018-2022)
12.7 Market Price for Each Type of Std Self Diagnostics in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Std Self Diagnostics Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Std Self Diagnostics
14. Std Self Diagnostics Competitive Landscape
14.1 Danaher Corporation
14.1.1 Danaher Corporation Company Profiles
14.1.2 Danaher Corporation Product Introduction
14.1.3 Danaher Corporation Std Self Diagnostics Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Affymetrix
14.2.1 Affymetrix Company Profiles
14.2.2 Affymetrix Product Introduction
14.2.3 Affymetrix Std Self Diagnostics Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 BioMerieux
14.3.1 BioMerieux Company Profiles
14.3.2 BioMerieux Product Introduction
14.3.3 BioMerieux Std Self Diagnostics Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Cepheid Inc.
14.4.1 Cepheid Inc. Company Profiles
14.4.2 Cepheid Inc. Product Introduction
14.4.3 Cepheid Inc. Std Self Diagnostics Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Bio-Rad Laboratories
14.5.1 Bio-Rad Laboratories Company Profiles
14.5.2 Bio-Rad Laboratories Product Introduction
14.5.3 Bio-Rad Laboratories Std Self Diagnostics Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Alere Inc.
14.6.1 Alere Inc. Company Profiles
14.6.2 Alere Inc. Product Introduction
14.6.3 Alere Inc. Std Self Diagnostics Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 DiaSorin
14.7.1 DiaSorin Company Profiles
14.7.2 DiaSorin Product Introduction
14.7.3 DiaSorin Std Self Diagnostics Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Orasure
14.8.1 Orasure Company Profiles
14.8.2 Orasure Product Introduction
14.8.3 Orasure Std Self Diagnostics Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 F. Hoffmann-La Roche
14.9.1 F. Hoffmann-La Roche Company Profiles
14.9.2 F. Hoffmann-La Roche Product Introduction
14.9.3 F. Hoffmann-La Roche Std Self Diagnostics Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Abbott Laboratories
14.10.1 Abbott Laboratories Company Profiles
14.10.2 Abbott Laboratories Product Introduction
14.10.3 Abbott Laboratories Std Self Diagnostics Sales, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Becton Dickinson and Company
14.12 Hologic Inc.
15. Conclusion